Adaptive Biotechnologies (NASDAQ:ADPT) Price Target Raised to $15.00 at Piper Sandler : vimarsana.com

Adaptive Biotechnologies (NASDAQ:ADPT – Get Rating) had its target price boosted by analysts at Piper Sandler from $14.00 to $15.00 in a note issued to investors on Monday, The Fly reports. Piper Sandler’s price objective suggests a potential upside of 134.38% from the stock’s current price. ADPT has been the subject of a number of […]

Related Keywords

Chad , Piper Sandler , Stacyl Taylor , Harlan Robins , R Mark Adams , Healthcare Of Ontario Pension Plan Trust Fund , Morgan Stanley , Adaptive Biotechnologies Corp , Credit Suisse Group , Metlife Investment Management , Securities Exchange Commission , Meeder Asset Management Inc , Financial Services Group Inc , Adaptive Biotechnologies , Get Rating , Suisse Group , Exchange Commission , Mark Adams , Services Group , Asset Management , Life Investment Management , Ontario Pension Plan Trust Fund , Chad Robins , Chris Carlson , Adaptive Biotechnologies Daily , Nasdaq Adpt , Adpt , Medical , Boost Price Target ,